Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design - Top-Institutions - MDSpire

Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design

  • By

  • Josh Michaud

  • Jennifer Kates

  • April 30, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Disease Epidemiology
    • Vaccine Effectiveness Research
    • Public Health Surveillance

  • #2

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Infectious Diseases
    • Vaccine Research

  • #3

    University of Washington, Institute for Health Metrics and Evaluation (IHME)
    University of Washington, Institute for Health Metrics and Evaluation (IHME)

    Seattle, WA

    Key Differentiators

    • Global Health Metrics
    • Epidemiology
    • Vaccine Effectiveness Modeling

  • #4

    Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health

    Boston, MA

    Key Differentiators

    • Epidemiology
    • Infectious Diseases
    • Vaccine Research

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Effectiveness

Original Source(s)

Estimating Effectiveness of Influenza and COVID-19 Vaccines: The “Test-Negative” Design

  • by Josh Michaud, Jennifer Kates

  • April 30, 2026

Related Content

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Impact of COVID-19 history on the prevalence of coronary slow flow: a comparative study in unstable angina patients

Self-administered digital vaccination decision-aids in primary care: A pilot study of COVID-19 vaccination in Atlanta, GA